NSEOutcome of Board MeetingDivestiture20 Aug 2026
Rubfila International Limited
Outcome of Board Meeting
Rubfila International Limited has informed the Exchange regarding Outcome of Board Meeting held on August 20, 2026, where the Board approved the proposed divestment of the Company's entire shareholding in Premier Tissues (India) Limited to M/s. Finquest Personal Care Pvt. Ltd. for an aggregate consideration of €61.00 crore, subject to shareholder and regulatory approvals.
NSECopy of Newspaper PublicationResults19 Aug 2026
Rubfila International Limited
Copy of Newspaper Publication
Rubfila International Limited has submitted unaudited financial results for the quarter ended 30th June, 2026, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
NSETrading Window13 Aug 2026
Rubfila International Limited
Trading Window
Rubfila International Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window for dealing in Company's Shares stands closed from 14th August, 2026 and shall re-open after 48 hours from the conclusion of the Board Meeting.
NSEStructural Digital DatabaseRegulatory12 Aug 2026
Rubfila International Limited
Structural Digital Database
Rubfila International Limited submitted a compliance certificate to SEBI for the quarter ended June 30, 2026, as per the SEBI (Prevention of Insider Trading) Regulations 2015.
NSEOutcome of Board Meeting▲ PositiveResults11 Aug 2026
Rubfila International Limited
Outcome of Board Meeting
Rubfila International Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹806.13 lakhs and a net profit of ₹599.70 lakhs.
NSEChange in Director(s)Mgmt Change16 Jul 2026
Rubfila International Limited
Change in Director(s)
Rubfila International Limited has informed the Exchange regarding Change in Director(s) of the company. Mr. Bharat J Dattani has tendered his resignation from the directorship of the Company vide letter dated 15th July, 2026.
NSEResignation of Director/KMP/SMPMgmt Change16 Jul 2026
Rubfila International Limited
Resignation of Director/KMP/SMP
Rubfila International Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
NSEResignationMgmt Change16 Jul 2026
Rubfila International Limited
Resignation
Rubfila International Limited has informed the Exchange regarding the resignation of Mr. Bharat Datt as Non-Executive Director of the company, effective July 16, 2026. The resignation was accepted by the Non-Executive Chairman on the same day. The reason for the resignation is as per SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIRI2023/123 dated July 13, 2023.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20184 Jul 2026
Rubfila International Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Rubfila International Limited has filed a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended June 30, 2026.
NSETrading WindowRegulatory29 Jun 2026
Rubfila International Limited
Trading Window
Rubfila International Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
NSEDisclosure under SEBI Takeover Regulations19 Jun 2026
Rubfila International Limited
Disclosure under SEBI Takeover Regulations
Rubfila International Limited announced a disclosure received from Minal Bharat Patel under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation specifically mandates promoters or controlling persons to disclose reasons for encumbrance, such as pledging, of their shares.
The current announcement does not detail specific financial figures or the quantity of shares involved. For investors, this disclosure signals a potential change in the pledged status of holdings by a significant individual. Reviewing the complete disclosure document is crucial to understand its implications on promoter control or financial stability.